Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb;16(2):405-21.
doi: 10.1089/ten.tea.2009.0454.

Scalable stirred-suspension bioreactor culture of human pluripotent stem cells

Affiliations
Review

Scalable stirred-suspension bioreactor culture of human pluripotent stem cells

Daniel E Kehoe et al. Tissue Eng Part A. 2010 Feb.

Abstract

Advances in stem cell biology have afforded promising results for the generation of various cell types for therapies against devastating diseases. However, a prerequisite for realizing the therapeutic potential of stem cells is the development of bioprocesses for the production of stem cell progeny in quantities that satisfy clinical demands. Recent reports on the expansion and directed differentiation of human embryonic stem cells (hESCs) in scalable stirred-suspension bioreactors (SSBs) demonstrated that large-scale production of therapeutically useful hESC progeny is feasible with current state-of-the-art culture technologies. Stem cells have been cultured in SSBs as aggregates, in microcarrier suspension and after encapsulation. The various modes in which SSBs can be employed for the cultivation of hESCs and human induced pluripotent stem cells (hiPSCs) are described. To that end, this is the first account of hiPSC cultivation in a microcarrier stirred-suspension system. Given that cultured stem cells and their differentiated progeny are the actual products used in tissue engineering and cell therapies, the impact of bioreactor's operating conditions on stem cell self-renewal and commitment should be considered. The effects of variables specific to SSB operation on stem cell physiology are discussed. Finally, major challenges are presented which remain to be addressed before the mainstream use of SSBs for the large-scale culture of hESCs and hiPSCs.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Human embryonic stem cells (hESCs) propagated as aggregates in stirred-suspension culture. (A) H1 hESC colonies were dissociated into single cells using accutase in the presence of the Rho-associated kinase (ROCK) inhibitor Y-27632. Single cells were incubated in mouse embryonic fibroblast (mEF)-conditioned medium with 10% Matrigel (to facilitate initial aggregation) and 10 μM Y-27632 for 30 min. Subsequently, the cell suspension was introduced into spinner flasks with mEF-conditioned medium and the agitation rate was set to 60 rpm. The cells formed stable aggregates and grew as shown in the micrographs from days 0, 2, 3, to 7. (B) Live cell concentration and viability of H1 hESCs cultured in a spinner flask with mEF-conditioned medium supplemented with Y-27632. The flask was seeded with 6 × 104 hESCs/mL. The upper arrow points indicates that cell viability values for the curve right under it should be read on the vertical axis on the right. Similarly, the lower arrow indicates that cell concentration values for the curve below this arrow are found on the vertical axis on the left. (C) Quantitative polymerase chain reaction was employed to probe the expression of pluripotency genes by hESCs cultured in the bioreactor (dark bars). White bars represent the expression of the corresponding genes in hESCs maintained in Matrigel-coated dishes (control). Values are shown as mean ± standard deviation (n = 3). (D) Cells from the bioreactor were plated and immunostained for OCT4 (green) and SSEA-4 (red). Scale bars: (A) 200 μm, (D) 50 μm. Color images available online at www.liebertonline.com/ten.
FIG. 2.
FIG. 2.
Expansion of human induced pluripotent stem cells (hiPSCs) in a microcarrier bioreactor. Human iPSCs (B12-3, see Ref.) were seeded on Matrigel-coated beads and cultured in a spinner flask as described previously for the culture of hESCs on microcarriers. (A) Temporal profiles of hiPSC concentration and viability for different seeding cell densities: solid line with circles: 0.25 × 105 hiPSCs/mL; dashed line with squares: 0.5 × 105 hiPSCs/mL; dotted line with triangles: 1 × 105 hiPSCs/mL. The cells were cultured at 45 rpm. The efficiencies of initial attachment of hiPSCs on the beads for the above seeding densities are shown in the table as mean ± standard deviation. The upper arrow points indicates that cell viability values for the curve right under it should be read on the vertical axis on the right. Similarly, the lower arrow indicates that cell concentration values for the curve below this arrow are found on the vertical axis on the left. (B) hiPSCs on microcarriers on day 6. (C) hiPSCs dissociated from beads on day 8 were plated and stained for OCT3/4A (green) and SSEA4 (red), or (D) OCT3/4A (green) and TRA-1-60 (red). Scale bars: (B) 200 μm, (C, D) 20 μm. Color images available online at www.liebertonline.com/ten.
FIG. 3.
FIG. 3.
Solution of a population balance equation for mouse ESCs (mESCs) cultured as aggregates in a 100 mL-spinner flask. Approximately 2 × 104 mESCs/mL were seeded and cultured for 4 days at 60 rpm as described. Equation 12 was recast in terms of the logarithm of the mESC aggregate diameter d (i.e., formula image) instead of mass, assuming a spherical shape for single cells and aggregates. The von Smoluchowski kernel, formula image, was used and the equation was solved as described before. formula image is an average shear rate (Eq. 3) in the culture vessel. The collision efficiency formula image was estimated in 12-h intervals based on distributions of mESC aggregate sizes determined by image analysis of micrographs. (A) The first moment formula image of the density function formula image normalized to the total biomass (i.e., formula image, where formula image is the diameter of a single mESC) is shown for mESC aggregates. (B) Temporal profile of the total biomass. (C) Values for the average diameter of mESC aggregates at different times. Gray bars: simulation; black bars: experimental data. Color images available online at www.liebertonline.com/ten.

References

    1. Palsson B.O. Bhatia S.N. Tissue Engineering. Upper Saddle River, NJ: Pearson Prentice Hall; 2004.
    1. Jing D. Parikh A. Canty J.M. Tzanakakis E.S. Stem cells for heart cell therapies. Tissue Eng Part B Rev. 2008;14:393. - PMC - PubMed
    1. Ryan E.A. Lakey J.R. Paty B.W. Imes S. Korbutt G.S. Kneteman N.M. Bigam D. Rajotte R.V. Shapiro A.M. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51:2148. - PubMed
    1. Lock L.T. Tzanakakis E.S. Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng. 2007;13:1399. - PubMed
    1. Tzanakakis E.S. Hess D.J. Sielaff T.D. Hu W.S. Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng. 2000;2:607. - PubMed

Publication types

LinkOut - more resources